Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300069934Phase 4Completed
Phase 4, open-label trial of linaclotide in functional constipation (FC) (2 arms), sponsored by Chengdu Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: complete spontaneous bowel movement. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300069934.